Update in Antifungal Therapy of Dermatophytosis

@article{Gupta2008UpdateIA,
  title={Update in Antifungal Therapy of Dermatophytosis},
  author={Aditya K. Gupta and Elizabeth A. Cooper},
  journal={Mycopathologia},
  year={2008},
  volume={166},
  pages={353-367}
}
Treatment of dermatophyte infection involves primarily oral and/or topical formulations of azoles or allylamines, particularly itraconazole and terbinafine. Topical medications applied once or twice daily are the primary treatment indicated for tinea corporis/cruris, and tinea pedis/manuum. Use of oral antifungals may be practical where the tinea involvement is extensive or chronic, or where application of a topical is not feasible. For tinea unguium (onychomycosis) and tinea capitis, oral… Expand
New Antifungal Agents and New Formulations Against Dermatophytes
TLDR
Since 2008, there have not been additions to the oral antifungal armamentarium, with terbinafine, itraconazole, and fluconazole still in widespread use, albeit for generally more severe or recalcitrant infections. Expand
A Comparative Study of Efficacy of Oral Terbinafine and Oralitraconazole in Tinea Corporis / Tinea Cruris Infection
TLDR
Itraconazole was found to be the better antifungal in terms of clinical cure, mycological clearance and less need for extension of treatment than Terbinafine, and both drugs had a good safety profile and few minor adverse events. Expand
Efficacy of Topical 1% Oxiconazole Cream in the Treatment of Dermatophytosis
TLDR
Once daily topical administration of oxiconazole cream is highly effective in the treatment of superficial fungal infections of the skin. Expand
Topical and systemic antifungals in dermatology practice
TLDR
An overview of the general characteristics of dermatophytes, including their taxonomy and epidemiology, as well as the different clinical forms and laboratory diagnostics, are provided, which further classify the topical and systemic antifungal compounds currently used to treat dermatophyte infections. Expand
Antifungal resistance in dermatophytes: recent trends and therapeutic implications.
TLDR
This review provides a comprehensive account of the available literature on in-vitro resistance to clinically used antifungals among dermatophytes and apprise the readers of the relevant skin pharmacokinetics of each. Expand
Conventional and natural compounds for the treatment of dermatophytosis.
TLDR
The main objective of this work is to provide a state-of-the-art review on dermatophytes, dermatophytosis, and the existing treatments, both conventional and natural, such as chitosan and essential oils. Expand
Topical antifungal treatments for tinea cruris and tinea corporis.
TLDR
The effects of topical antifungal treatments in tinea cruris and tinea corporis are assessed to assess the effects of randomised controlled trials in people with proven dermatophyte infection of the body or groin. Expand
Onychomycosis: Novel strategies for treatment
TLDR
Effective and potential treatment methods like nanoparticles, polymeric films, liposomes and hydrogels are in need to be explored to achieve enhanced drug delivery in onychomycosis. Expand
Superficial fungal infections.
  • B. Kelly
  • Medicine
  • Pediatrics in review
  • 2012
TLDR
Tinea capitis, tinea corporis, and pityriasis versicolor are common superficial fungal infections in the pediatric population and topical topical therapy for the patient and household contacts decreases transmission of this infection. Expand
Update on therapy for superficial mycoses: review article part I*
TLDR
The main treatments for superficial mycoses are discussed - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs, referring also to their dosage and duration of use. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 74 REFERENCES
Traditional management of onychomycosis.
  • C. R. Daniel
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1996
TLDR
Both griseofulvin and ketoconazole have numerous potential side effects and drug/drug interactions and they should be used only after evaluation of the patient's current medical status and a review of concomitant medications. Expand
New treatments for tinea capitis
TLDR
Short-term terbinafine, itraconazole and fluconazole therapy have been shown to be comparable in efficacy and safety with griseofulvin, and many experts consider griseOfulvin to be the drug of choice for tinea capitis. Expand
Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris.
TLDR
Itraconazole, 200 mg daily for 7 days, offers a short convenient and effective treatment option for tinea corporis and tinea cruris. Expand
The use of oral antifungal agents to treat onychomycosis.
TLDR
The introduction of the azoles (ketoconazoles, itraconazole, and fluconazole) and the allylamine, terbinafine, led to improved cure rates and a broad spectrum of activity. Expand
Dermatophytosis: The Management of Fungal Infections
TLDR
Terbinafine, itraconazole, and fluconazole are oral antimycotics that are effective in the treatment of superficial mycoses, although, depending on the severity of the infection, a topical antifungal may be sufficient. Expand
Treatments of tinea pedis.
TLDR
The severity of tinea pedis infection determines the course of treatment required, and it may be necessary to combine an antifungal agent with an antibacterial agent. Expand
Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
TLDR
Itraconazole PT is effective and safe in the treatment of tinea pedis/manuum, tinea corporis/cruris, and onychomycosis. Expand
Systemic antifungal agents: an update of established and new therapies.
  • D. Loo
  • Medicine
  • Advances in dermatology
  • 2006
TLDR
The current role of second-generation triazoles and echinocandins is for treatment of invasive candidiasis and invasive aspergillosis in patients who are critically ill and immunocompromised. Expand
Fluconazole in the Treatment of Tinea corporis and Tinea cruris
TLDR
Fluconazole 150 mg once weekly for 2–4 weeks is an efficacious and safe regimen in the treatment of tinea corporis and cruris. Expand
Therapeutic options for the treatment of tinea capitis: Griseofulvin versus fluconazole
TLDR
Fluconazole constitutes an alternative but, because of greater availability and lower cost, griseofulvin remains the treatment of choice for tinea capitis. Expand
...
1
2
3
4
5
...